Arrowhead Pharmaceuticals
ARWR
#3841
Rank
€2.37 B
Marketcap
19,08 €
Share price
1.73%
Change (1 day)
-24.79%
Change (1 year)

EPS for Arrowhead Pharmaceuticals (ARWR)

EPS in 2023 (TTM): -1,65 €

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -1,53 €. In 2022 the company made an earnings per share (EPS) of -1,32 € an increase over its 2021 EPS that were of -1,59 €.

EPS history for Arrowhead Pharmaceuticals from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-1,65 €25.05%
2022-1,32 €-17.05%
2021-1,59 €74.26%
2020-0,91 €-283.64%
20190,50 €-257.14%
2018-0,32 €-27.08%
2017-0,43 €-59.32%
2016-1,06 €-21.85%
2015-1,36 €9.42%
2014-1,25 €2.87%
2013-1,21 €-31.56%
2012-1,77 €300%
2011-0,44 €-45.56%
2010-0,81 €-66.67%
2009-2,44 €-63.51%
2008-6,68 €-12.94%
2007-7,67 €44.07%
2006-5,32 €77.35%
2005-3,00 €10.66%
2004-2,71 €-54.25%
2003-5,93 €-80.51%
2002-30,43 €3.87%
2001-29,29 €116.17%
2000-13,55 €

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-3,71 € 141.76%🇺🇸 USA
1,42 €-192.35%🇺🇸 USA
-0,59 €-61.76%🇺🇸 USA
12,71 €-928.55%🇺🇸 USA
-8,25 € 437.65%🇺🇸 USA